Cargando…

Xuebijing Protects Rats from Sepsis Challenged with Acinetobacter baumannii by Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion

Xuebijing (XBJ) injection is a herbal medicine that has been widely used in the treatment of sepsis in China; however, its role in the development and progression of Acinetobacter baumannii sepsis and the underlying mechanisms remain uninvestigated. In the present study, fifty-four male Wistar rats...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xian-Di, Wang, Yan, Wu, Qiong, Wang, Hua-Xue, Chen, Zhen-Dong, Zheng, Rong-Sheng, Wang, Zi-Shu, Wang, Jun-Bin, Yang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863526/ https://www.ncbi.nlm.nih.gov/pubmed/24369483 http://dx.doi.org/10.1155/2013/804940

Ejemplares similares

Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production
por: Wang, Xin-Tong, et al.
Publicado: (2021)

Efficacy of Xuebijing for coagulopathy in patients with sepsis
por: Hou, Si-Yuan, et al.
Publicado: (2015)

Scientific Evidence of Xuebijing Injection in the Treatment of Sepsis
por: Tian, Sa, et al.
Publicado: (2021)

A Case-Control Study of Continuous Veno-Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis
por: Liu, Yan, et al.
Publicado: (2022)

Metabolomic Insights Into the Synergistic Effect of Biapenem in Combination With Xuebijing Injection Against Sepsis
por: Liu, Li-Wei, et al.
Publicado: (2020)

Novel assays for quality evaluation of XueBiJing: Quality variability of a Chinese herbal injection for sepsis management
por: Yu, Xuan, et al.
Publicado: (2022)

Detecting Critical Functional Ingredients Group and Mechanism of Xuebijing Injection in Treating Sepsis
por: Wu, Qi-, et al.
Publicado: (2021)

Acinetobacter baumannii Infection in Transfusion Dependent Thalassemia Patients with Sepsis
por: Muzaheed,, et al.
Publicado: (2017)

Xuebijing injection attenuates pulmonary injury by reducing oxidative stress and proinflammatory damage in rats with heat stroke
por: Chen, Yi, et al.
Publicado: (2017)

Uncovering the Secretion Systems of Acinetobacter baumannii: Structures and Functions in Pathogenicity and Antibiotic Resistance
por: Li, Pu, et al.
Publicado: (2023)

Xuebijing Ameliorates Sepsis-Induced Lung Injury by Downregulating HMGB1 and RAGE Expressions in Mice
por: Wang, Qiao, et al.
Publicado: (2015)

Xuebijing injection inhibited neutrophil extracellular traps to reverse lung injury in sepsis mice via reducing Gasdermin D
por: Shang, Ting, et al.
Publicado: (2022)

Protective effect of Xuebijing injection on paraquat-induced pulmonary injury via down-regulating the expression of p38 MAPK in rats
por: Liu, Ming-wei, et al.
Publicado: (2014)

Complete Genome Sequence of Acinetobacter baumannii ZW85-1
por: Wang, Xin, et al.
Publicado: (2014)

Therapy of compartmentalization of the proinflammatory and anti-inflammatory cytokines in sepsis
por: Grigoryev, EG
Publicado: (2010)

Evolution of Acinetobacter baumannii in Clinical Bacteremia Patients
por: Li, Henan, et al.
Publicado: (2021)

Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
por: Kuo, Shu-Chen, et al.
Publicado: (2015)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

The role of the type VI secretion system vgrG gene in the virulence and antimicrobial resistance of Acinetobacter baumannii ATCC 19606
por: Wang, Jianfeng, et al.
Publicado: (2018)

The effects of Xuebijing injection combined with ulinastatin as adjunctive therapy on sepsis: An overview of systematic review and meta-analysis
por: Zhong, Guofu, et al.
Publicado: (2022)

Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models
por: Huang, Weiwei, et al.
Publicado: (2014)

Acinetobacter baumannii Early-Onset Sepsis After Home Delivery Into Toilet Water
por: Sousa, Patrícia, et al.
Publicado: (2023)

Efficacy of Xuebijing Injection for Sepsis (EXIT-SEP): protocol for a randomised controlled trial
por: Liu, Songqiao, et al.
Publicado: (2019)

Acinetobacter baumannii Utilizes a Type VI Secretion System for Bacterial Competition
por: Carruthers, Michael D., et al.
Publicado: (2013)

Challenges in diagnosing community-acquired carbapenem-susceptible Acinetobacter baumannii enterogenic sepsis: A case report
por: Ye, Gongjie, et al.
Publicado: (2019)

Prevalence of different carbapenemase genes among carbapenem-resistant Acinetobacter baumannii blood isolates in Taiwan
por: Wang, Teng-Ho, et al.
Publicado: (2018)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Acinetobacter baumannii—The New MRSA?
por: Barrie, Alasdair, et al.
Publicado: (2016)

Glycosphingolipids Recognized by Acinetobacter baumannii
por: Madar Johansson, Miralda, et al.
Publicado: (2020)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2016)

Acinetobacter Baumannii Phages: Past, Present and Future
por: Tu, Qihang, et al.
Publicado: (2023)

Protective effect of Xuebijing injection on myocardial injury in patients with sepsis: a randomized clinical trial
por: Hongwei, Zhang, et al.
Publicado: (2016)

Xuebijing Administration Alleviates Pulmonary Endothelial Inflammation and Coagulation Dysregulation in the Early Phase of Sepsis in Rats
por: Lv, Jie, et al.
Publicado: (2022)

Resistant mechanisms and molecular epidemiology of imipenem-resistant Acinetobacter baumannii
por: Xiao, Shu-Zhen, et al.
Publicado: (2016)

Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
por: Vázquez-López, Rosalino, et al.
Publicado: (2020)

Acinetobacter baumannii response to cefiderocol challenge in human urine
por: Nishimura, Brent, et al.
Publicado: (2022)

Multidrug-resistant Acinetobacter baumannii: A therapeutic challenge
por: Pérez, María Martínez, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2dlg5nne2iv8u1576jstj4nq2g